Hypertension Pipeline Review, H1 2016 - 100 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Hypertension - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypertension) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Hypertension Overview
  3. Therapeutics Development
  4. Pipeline Products for Hypertension - Overview
  5. Pipeline Products for Hypertension - Comparative Analysis
  6. Hypertension - Therapeutics under Development by Companies
  7. Hypertension - Therapeutics under Investigation by Universities/Institutes
  8. Hypertension Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Hypertension - Products under Development by Companies
  13. Hypertension - Products under Investigation by Universities/Institutes
  14. Hypertension - Companies Involved in Therapeutics Development
  • A1M Pharma AB
  • AbbVie Inc.
  • Ache Laboratorios Farmaceuticos S/A
  • Actelion Ltd
  • Afferent Pharmaceuticals, Inc.
  • Allergan Plc
  • Alnylam Pharmaceuticals, Inc.
  • Anacor Pharmaceuticals, Inc.
  • APT Therapeutics, Inc.
  • Arena Pharmaceuticals, Inc.
  • Ascendis Pharma A/S
  • AVEO Pharmaceuticals, Inc.
  • Bayer AG
  • Bial - Portela & Ca, S.A.
  • Bio-inRen
  • BioRestorative Therapies, Inc.
  • Bristol-Myers Squibb Company
  • Cellceutix Corporation
  • Celsion Corporation
  • Celtaxsys, Inc.
  • Chong Kun Dang Pharmaceutical Corp.
  • CJ HealthCare Corp.
  • Complexa, Inc.
  • Conatus Pharmaceuticals Inc.
  • Cytokinetics, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Daiichi Sankyo Company, Limited
  • Yuhan Corporation

For more information visit http://www.researchandmarkets.com/research/5grv5g/hypertension

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Drugs